Michael Cecchini

1.1k total citations
79 papers, 601 citations indexed

About

Michael Cecchini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Michael Cecchini has authored 79 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Michael Cecchini's work include Colorectal Cancer Treatments and Studies (15 papers), Cancer Genomics and Diagnostics (12 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Michael Cecchini is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Cancer Genomics and Diagnostics (12 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Michael Cecchini collaborates with scholars based in United States, United Kingdom and Japan. Michael Cecchini's co-authors include Timil Patel, Jill Lacy, Howard S. Höchster, Atsushi Ohtsu, Takayuki Yoshino, Daisuke Kotani, Pashtoon Murtaza Kasi, Ramesh K. Ramanathan, Stacey Stein and Kohei Shitara and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael Cecchini

70 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Cecchini United States	12	297	161	151	111	87	79	601
Yunan Han United States	16	337 1.1×	216 1.3×	152 1.0×	137 1.2×	53 0.6×	39	705
Adam C. ElNaggar United States	13	238 0.8×	91 0.6×	173 1.1×	133 1.2×	95 1.1×	68	579
Syed A. Ahmed United States	10	304 1.0×	107 0.7×	224 1.5×	149 1.3×	42 0.5×	16	644
Raimondo Di Liello Italy	13	357 1.2×	228 1.4×	265 1.8×	113 1.0×	39 0.4×	33	738
Leung Li Hong Kong	14	209 0.7×	104 0.6×	132 0.9×	98 0.9×	82 0.9×	33	571
Anne S. Quante Germany	12	369 1.2×	94 0.6×	213 1.4×	117 1.1×	51 0.6×	30	695
Nikolaos Syrigos Greece	12	279 0.9×	190 1.2×	187 1.2×	91 0.8×	53 0.6×	61	599
Friedrich Overkamp Germany	13	356 1.2×	204 1.3×	149 1.0×	206 1.9×	41 0.5×	64	592
Domenico Sergi Italy	16	359 1.2×	166 1.0×	178 1.2×	157 1.4×	82 0.9×	54	796
Fadi Farhat Lebanon	17	196 0.7×	234 1.5×	188 1.2×	82 0.7×	50 0.6×	55	684

Countries citing papers authored by Michael Cecchini

Since Specialization

Citations

This map shows the geographic impact of Michael Cecchini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cecchini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cecchini more than expected).

Fields of papers citing papers by Michael Cecchini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Cecchini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cecchini. The network helps show where Michael Cecchini may publish in the future.

Co-authorship network of co-authors of Michael Cecchini

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Cecchini. A scholar is included among the top collaborators of Michael Cecchini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Cecchini. Michael Cecchini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Long, Jessica B., Terry Hyslop, Andrea Silber, et al.. (2025). Risk of Late-Onset Depression in Long-Term Survivors of Breast, Prostate, and Colorectal Cancer. JAMA Network Open. 8(11). e2544812–e2544812.

Janjigian, Yelena Y., Michael Cecchini, Kohei Shitara, et al.. (2025). Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies. JCO Precision Oncology. 9(9). e2400456–e2400456. 1 indexed citations

Coté, Gregory M., Michael Cecchini, Moh’d Khushman, et al.. (2025). 2688MO A phase I/II trial of FOG-001, a first-in-class direct β-catenin:TCF4 inhibitor - Safety and preliminary antitumor activity in patients with desmoid tumors. Annals of Oncology. 36. S1339–S1340.

Liu, Sean, Biren Reddy, Ricarda Tomlin, et al.. (2025). A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colorectal Adenocarcinoma with Peritoneal Metastasis. Annals of Surgical Oncology. 32(8). 5784–5794.

Uhlig, Johannes, Joanna Gibson, Michael Cecchini, et al.. (2024). Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms. Scientific Reports. 14(1). 30536–30536. 5 indexed citations

Heumann, Thatcher, Michael Cecchini, Raid Aljumaily, et al.. (2024). A phase I study of irinotecan combined with BAY1895344 (ATR inhibitor) in advanced solid tumors: Results of ETCTN 10402 dose escalation.. Journal of Clinical Oncology. 42(16_suppl). 3077–3077. 1 indexed citations

Kim, Sunkyu, Seung‐seob Kim, Eejung Kim, et al.. (2024). Deep-Transfer-Learning–Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting Survival of Patients With Pancreatic Cancer. JCO Clinical Cancer Informatics. 8(8). e2400021–e2400021. 2 indexed citations

Cecchini, Michael, Raid Aljumaily, Þorvarður R. Hálfdánarson, et al.. (2024). A phase I study of ATR inhibitor BAY1895344 (elimusertib) plus topotecan (ETCTN 10402): Results of dose escalation.. Journal of Clinical Oncology. 42(16_suppl). 3076–3076. 3 indexed citations

Sen, Shiraj, Alexander I. Spira, David Sommerhalder, et al.. (2023). 1079TiP A phase I first-in-human study of PRTH-101, an IgG1 monoclonal antibody targeting DDR1, as a monotherapy and combined with pembrolizumab in patients with advanced solid malignancies. Annals of Oncology. 34. S649–S650. 2 indexed citations

10.

Cecchini, Michael, Janie Y. Zhang, Wei Wei, et al.. (2023). Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer Research Communications. 3(6). 1132–1139. 4 indexed citations

11.

Cecchini, Michael, Zenta Walther, Wei Wei, et al.. (2023). NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors. Cancer Research Communications. 3(6). 1113–1117. 2 indexed citations

12.

Lacy, Jill, Michael Cecchini, Jeremy Kortmansky, et al.. (2023). Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancer. Journal of Gastrointestinal Oncology. 14(3). 1181–1192. 3 indexed citations

13.

Li, Chen, Ana Ferro, Shivani K. Mhatre, et al.. (2022). Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer. SHILAP Revista de lepidopterología. 2(1). 90–90. 13 indexed citations

14.

Guo, Yang, et al.. (2021). Can a simplified CT response criteria for vascular involvement in pancreatic adenocarcinoma after neoadjuvant therapy predict survival in patients who achieved subsequent R0 resection?. Abdominal Radiology. 46(12). 5609–5617. 2 indexed citations

15.

Janjigian, Y. Y., Michael Cecchini, Kohei Shitara, et al.. (2021). 1416P Genomic landscape of late-stage gastric cancer. Annals of Oncology. 32. S1062–S1063. 3 indexed citations

16.

Patel, Timil, Joseph A. Miccio, Michael Cecchini, et al.. (2021). Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System. Journal of Gastrointestinal Oncology. 12(6). 2547–2556. 3 indexed citations

17.

Cecchini, Michael, Zenta Walther, Jeffrey Sklar, et al.. (2017). Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes. The Lancet Oncology. 19(1). 23–24. 4 indexed citations

18.

Kotani, Daisuke, Michael Cecchini, Kohei Shitara, et al.. (2016). PD-010 Association between chemotherapy-induced neutropenia at 1-month and overall survival in patients receiving TAS-102 for metastatic colorectal cancer. Annals of Oncology. 27. ii105–ii105. 2 indexed citations

19.

Kasi, Pashtoon Murtaza, Daisuke Kotani, Michael Cecchini, et al.. (2016). Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study. BMC Cancer. 16(1). 467–467. 57 indexed citations

20.

Nante, Nicola, et al.. (2008). Sex differences in use of interventional cardiology persist after risk adjustment. Journal of Epidemiology & Community Health. 63(3). 203–208. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact